208 related articles for article (PubMed ID: 19458108)
1. Erythropoiesis-stimulating agents: creation and validation of a computerized prescriber order entry alert.
Ensor CR; Kockler DR; Dugger RW; Hylton-Gravatt LA
Ann Pharmacother; 2009 Jun; 43(6):1143-4. PubMed ID: 19458108
[No Abstract] [Full Text] [Related]
2. Updated clinical practice guidelines on erythropoiesis-stimulating agents.
Silver SM
Clin Adv Hematol Oncol; 2007 Dec; 5(12):945-6. PubMed ID: 18277954
[No Abstract] [Full Text] [Related]
3. Erythropoiesis-stimulating agents in cancer.
Arcasoy MO
J Clin Oncol; 2008 Jun; 26(18):3097-8; author reply 3098-100. PubMed ID: 18565902
[No Abstract] [Full Text] [Related]
4. Reconsideration of American Society of Clinical Oncology/American Society of Hematology Erythropoiesis-stimulating Agent Guidelines.
Murray N; Klasa R
J Clin Oncol; 2008 Jun; 26(18):3096-7. PubMed ID: 18565901
[No Abstract] [Full Text] [Related]
5. Be wary of recommending off-label use of meds.
Luttrull S
Adv Nurse Pract; 2001 Feb; 9(2):18. PubMed ID: 12416047
[No Abstract] [Full Text] [Related]
6. Reevaluating erythropoiesis-stimulating agents.
Cotter DJ
N Engl J Med; 2010 May; 362(18):1743; author reply 1743-4. PubMed ID: 20449881
[No Abstract] [Full Text] [Related]
7. Blueprint for prescriber continuing education program.
Center For Drug Evaluation And Research Food And Drug Administration
J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):127-30. PubMed ID: 22764849
[TBL] [Abstract][Full Text] [Related]
8. Erythropoiesis-stimulating agents in patients with cancer: update on safety issues.
Pirker R
Expert Opin Drug Saf; 2009 Sep; 8(5):515-22. PubMed ID: 19637988
[TBL] [Abstract][Full Text] [Related]
9. Ordering off the menu: assessing compliance with a nonformulary medication policy.
Pummer TL; Shalaby KM; Erush SC
Ann Pharmacother; 2009 Jul; 43(7):1251-7. PubMed ID: 19584383
[TBL] [Abstract][Full Text] [Related]
10. E-prescribing.
State Legis; 2008 Feb; 34(2):9. PubMed ID: 18429355
[No Abstract] [Full Text] [Related]
11. Computerized physician order entry systems: the coming of age for outpatient medicine.
Davis RL
PLoS Med; 2005 Sep; 2(9):e290. PubMed ID: 16173835
[TBL] [Abstract][Full Text] [Related]
12. Hemoglobin variability as a predictor of mortality: What's a practitioner to do?
Wish JB
Am J Kidney Dis; 2011 Feb; 57(2):190-3. PubMed ID: 21251539
[No Abstract] [Full Text] [Related]
13. Getting to 100%: a framework to define and reach target order entry rates.
Pattullo A; Jamieson P; Kraft S; Robert J; Ross S; Abelseth G; Rosenal T
Stud Health Technol Inform; 2009; 143():380-8. PubMed ID: 19380965
[TBL] [Abstract][Full Text] [Related]
14. Computerized physician order entry with decision support decreases blood transfusions in children.
Adams ES; Longhurst CA; Pageler N; Widen E; Franzon D; Cornfield DN
Pediatrics; 2011 May; 127(5):e1112-9. PubMed ID: 21502229
[TBL] [Abstract][Full Text] [Related]
15. Using quality-improvement methods to reduce variation in surfactant administration.
Bookman L; Troy R; McCaffrey M; Randolph G
Qual Saf Health Care; 2010 Oct; 19(5):e23. PubMed ID: 20595716
[TBL] [Abstract][Full Text] [Related]
16. Physician-specific OPPE models in academic medical centers.
Rebagliati GS
Ann Surg; 2009 Apr; 249(4):700-1. PubMed ID: 19300215
[No Abstract] [Full Text] [Related]
17. Distinguishing product and practice regulation in personalized medicine.
Evans BJ
Clin Pharmacol Ther; 2007 Feb; 81(2):288-93. PubMed ID: 17259953
[TBL] [Abstract][Full Text] [Related]
18. Thinking outside the (black) box: a new research agenda.
Seligman PJ
Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):387-9. PubMed ID: 16739245
[No Abstract] [Full Text] [Related]
19. Message to the FDA on ESAs: REMS is not enough, more studies are needed.
Singh AK
Clin J Am Soc Nephrol; 2010 Aug; 5(8):1355-8. PubMed ID: 20688885
[No Abstract] [Full Text] [Related]
20. Blind Pew sends a black spot: the current haemoglobin controversy.
Stevens PE
Blood Purif; 2008; 26(1):54-8. PubMed ID: 18182797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
